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Cardiomyocyte differentiationAutophagy plays important roles in adipogenesis and neuron development. However, how autophagy contrib-
utes to cardiac development is not well understood. The main aim of our study was to determine the association
between autophagy and myocardial differentiation and its roles in this process. Using a well-established in vitro
cardiomyocyte differentiation system, P19CL6 cells, we found that autophagy occurred from the early stage of
cardiac differentiation. Blocking autophagy by knocking-down of autophagy-related gene Atg7 or Atg5 inhibited
the cardiac differentiation of P19CL6 cells. Further investigation demonstrated that LC3 and P62 could form a
complexwithβ-catenin andNICD, respectively, and promoted the degradation ofβ-catenin andNICD. Enhancing
autophagy promoted the formation of complex, whereas blocking autophagy attenuated the degradation of β-
catenin and NICD. Taken together, autophagy could facilitate P19CL6 cells to complete the cardiac differentiation
process through blocking Wnt and Notch signaling pathways.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
The heart is the ﬁrst organ to be formed frommesodermal cells dur-
ing embryogenesis, and all subsequent events in the life of the organism
depend on its uninterrupted contractility. Heart development is an ex-
traordinarily complex process involving the integration of multiple
cell lineages into the 3D organ and its seamless connection to the vascu-
lar system [1], its developmental process is controlled by many signal
pathways, such asWnt, Notch, BMP and FGF [2]. Wnt and Notch signal-
ing pathways play important roles in heart development, and emerging
evidence has shown crosstalk between Wnt and Notch pathways [3].
Wnts are a family of secreted signaling proteins, which have amajor
inﬂuence on embryonic development, tumor progression, and stem cell
differentiation. It has been demonstrated to have a biphasic role in
cardiogenesis. At the early stage of cardiac development, it promotes
cardiomyocyte differentiation, whereas at the later stage, Wnt signaling
inhibits cardiogenesis [4]. That means Wnt signaling has differential
stage-speciﬁc effects, functioning in either an agonistic or antagonistic
fashion.
Notch signaling, another important pathway in cardiac differentia-
tion, is thought to inhibit cardiac differentiation. ES cells deﬁcient in
the Notch downstream effector RBP-Jk generate more cardiomyocytes.
. This is an open access article underthanwild-type counterparts,whereas ES cells expressing a constitutive-
ly active form of theNotch1 receptor display a reduced cardiac differen-
tiation potential [5].
Although these studies collectively show that Notch signaling has
inhibitory roles at a speciﬁc stage of the cardiac differentiation, some re-
searchers demonstrate that Notch1 is required for cardiac progenitor
cells differentiating into cardiomyocytes by positively regulating the
expression of cardiac transcription factors in mice embryos and ES
cells [6–10]. We previously investigated the interplay between Wnt
andNotch signalingpathways during cardiomyogenesis in a pluripotent
mouse embryonic carcinoma cell line (P19CL6). We found that Notch1
signaling interacts with Wnt/β-catenin pathway and plays a biphasic
role at the early stage of cardiac differentiation [3]. But at the late differ-
entiation stage, the component molecules of Wnt and Notch pathways
are quitted from the differential process quickly. The mechanism is
not clear.
It is well known that the degradation of intracellular proteins is
involved in the regulation of a series of cellular processes, including
cell-cycle division, DNA repair, cell growth and differentiation, apopto-
sis, etc. All proteins in eukaryotic cells are continually being degraded
and replaced. Autophagy and the ubiquitin–proteasome system are
two mechanisms for intracellular protein degradation [11]. Autophagy
is mediated by lysosome, and is further divided into chaperone-
mediated autophagy, microautophagy and macroautophagy. It is be-
lieved that Atg5 and Atg7 are essential genes for mammalian autophagythe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Table 1
Primers used for quantitative real-time RT-PCR.
Primers Sequence (5′–3′) Product size
Isl1 F: CTGCTTTTCAGCAACTGGTCA 123
R: TAGGACTGGCTACCATGCTGT
Gata4 F: CACCCCAATCTCGATATGTTTGA 151
R: GGTTGATGCCGTTCATCTTGT
α-Mhc F: GCCCAGTACCTCCGAAAGTC 110
R: GCCTTAACATACTCCTCCTTGTC
β-Mhc F: ACAACCCCTACGATTATGCGT 100
R: ACGTCAAAGGCACTATCCGTG
Troponin T F: GGCAGAACCGCCTGGCTGAA 109
R: CTGCCACAGCTCCTTGGCCT
Wnt3a F: TGGCTGAGGGTGTCAAAGC 181
R: CGTGTCACTGCGAAAGCTACT
NICD F: CCCTTGCTCTGCCTAACGC 162
R: GGAGTCCTGGCATCGTTGG
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by ubiquitin, which participates in intracellular protein degradation in a
speciﬁc manner [13].
It has been reported that the inhibition of the ubiquitin–proteasome
pathway blocked the decrease of β-catenin and resulted in the accumu-
lation of bothβ-catenin andplakoglobin in the nucleus [14].Meanwhile,
the substitution of the serine residues in the glycogen synthase kinase
3β (GSK3β) phosphorylation consensus motif of β-catenin inhibited
ubiquitination and provided the ﬁrst evidence that the ubiquitin–
proteasome degradation pathway may act downstream of GSK3β in the
regulation of β-catenin [15]. For Notch receptors, monoubiquitylation
and endocytosis are prerequisites for efﬁcient receptor activation and
signaling [16]. The ubiquitylation of Notch receptor ligands is required
for ligand endocytosis in the signal-sending cell and Notch signaling
in the signal-receiving cell [17]. These literatures suggest that the intra-
cellular protein degradation is essential for the cells.
Autophagy is also reported to be related withWnt and Notch signal-
ing pathways in different cell models. Autophagy negatively regulates
Wnt signaling by promoting Disheveled (Dvl) degradation in the late
stages of colon cancer development [18]. β-Catenin suppressed auto-
phagosome formation and directly repressed the autophagy adaptor
P62 expression [19]. In Drosophila oogenesis, the loss of autophagy
leads to the activation of the Notch signal [20]. However, whether au-
tophagy regulates Wnt and Notch signaling pathways in cardiac differ-
entiation is not well understood.
In this study, we investigated the impact of autophagy during
the cardiac differentiation process of P19CL6 cells, a well-established
in vitro cardiomyocyte differentiation system (Fig. S1) [21]. We found
that autophagy begins to occur at the early stage, and maintains at a
high level during cardiomyocyte terminal differentiation. β-Catenin
and NICD, as the effectors of Wnt and Notch signaling pathways, could
form a complex with LC3 and P62 and be degraded by autophagy. As
both Notch and Wnt pathways play inhibitory roles in the late stage of
cardiac differentiation, the appropriate clearance of the components of
two pathways could facilitate P19CL6 cells to complete the cardiac dif-
ferentiation process.
2. Materials and methods
2.1. Cell culture
P19CL6 cell line was established in 1996 [22] and was used in this
study. These cells are embryonic carcinoma cells that can be induced
with 1% dimethyl sulfoxide (DMSO) into cardiomyocyte like beating
cells. The induced cells express speciﬁc cardiacmarkers in a stage specif-
ic manner: NKX2.5, ISL1, α-cardiac myosin heavy chain (MHC), sarco-
mere myosin (MF20) and troponin T, troponin I, etc. This cell line has
been used as a good model to study the mechanism of cardiac differen-
tiation [21] since then. P19CL6 cells were cultured as described previ-
ously [23]. In brief, the cells were grown in a 60-mm tissue culture
dish with growth medium containing α-minimal essential medium
(Gibco BRL) supplemented with 10% fetal bovine serum (FBS, Hyclone
USA), penicillin (100 U/ml) and streptomycin (100 mg/ml), and were
maintained in a 5% CO2 atmosphere at 37 °C. To induce cardiac differen-
tiation, P19CL6 cells were plated at a density of 3.7× 105 in a 60-mmtis-
sue culture dish with the growth medium containing 1% dimethyl
sulfoxide (DMSO). The medium was changed every 2 days. The days
of differentiation were numbered consecutively beginning at the ﬁrst
day of the DMSO treatment (day 0).
2.2. Construction of Atg7 or Atg5 knockdown cell lines
Atg5/GV102RNAi construct (GCTTTACTCTCTATCAGGATGAGATTTC
AAG AGAATCTCATCCTGATAGAGAGTAAAGC) and Atg7/GV102RNAi
construct (CCAAGGTCAAAGGACAAAGATCTCGAGATCTTTGTCCTTTGACC
TTGG)were synthesizedby Shanghai GeneChemCo., Ltd. The transfectionof the plasmids was performed using Lipofectamine 2000 (Invitrogen,
Carlsbad, CA, USA) according to the manufacturer's protocols. To create
stable cell lines, 2 × 105 P19CL6 cells were plated onto a 60-mm culture
dish. When the cells reached approximately 50% conﬂuence, P19CL6
cells were transfectedwith 5 μg Atg5 RNAi plasmid, Atg7 RNAi plasmid,
and the scrRNAi plasmid using Lipofectamine 2000. G418 selection
(1000 μg/ml) was continued for 7 days. The identiﬁcation of stable
cell lines was performed by examination for expression of Atg7 and
Atg5, respectively.2.3. Luciferase reporter construction and luciferase assays
P19CL6 cellswere plated into 24-well plates at 5×104 cells/well 24 h
before transfection. TOP/FOP Flash, Hes1 luc, Hey1 luc plasmids
(400 ng) and 20 ng control Renilla vector (phRLTK, Promega) were
cotransfected with 2 μl transfection reagent (Lipo 2000). Lysates were
collected 36 h after transfection, and luciferase activity was measured
with the dual luciferase assay (Promega).2.4. Western blotting analysis
Total protein extractswere obtainedwith lysis buffer (150mMNaCl,
10mMTris [pH 7.2], 5mMEDTA, 0.1% sodium dodecyl sulfate [SDS], 1%
sodium deoxycholate, 1% Triton X-100) containing protease inhibitor
cocktail (Sigma). Proteins were separated by electrophoresis on 8–15%
SDS-polyacrylamide gels, transferred to nitrocellulose, and incubated
with corresponding primary antibodies.
LC3, Atg5, P62 and Ub antibodies were purchased from MBL Co.;
Atg7 antibody was purchased from CST Co.; β-catenin, NICD and
GATA4 antibodies were purchased from Santa Cruz Co.; Troponin T
antibodies were purchased from Abcam Co.; MF20 antibody was from
Developmental Studies Hybridoma Bank, the University of Iowa.; α-
actinin antibody was purchased from Sigma Co. The membrane was
also probed for mouse glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) as a loading control. The blots were next incubated with
peroxidase-conjugated IgG secondary antibody and developed using
the enhanced chemiluminescence kit (Millipore).2.5. Quantitative real-time RT-PCR
For mRNA analysis, total RNA was isolated with TRIzol reagent
(Invitrogen), and 5 μg total RNA was reverse transcribed with random
primers for cDNA synthesis in the presence of RNase inhibitor (Vigor-
ous). The cDNAwas used for quantitative RT-PCR with speciﬁc primers.
Transcript levels were normalized to 18S rRNA level. The primers are
listed in Table 1. Each value represents the average of at least three in-
dependent experiments.
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For confocal microscopy, cells were cultured on confocal dishes for
24 h and then were ﬁxed with 4% formaldehyde, permeabilized with
phosphate-buffered saline containing 0.1% Triton X-100, and incubated
with corresponding primary antibodies, which was followed by incuba-
tion with the secondary antibody conjugated to Alexa Fluor 488. Nuclei
were stained with Hoechst 33342. The confocal dishes were examined
with an Olympus confocal microscope (Olympus Corporation, Tokyo,
Japan).
2.7. Co-immunoprecipitation assay
Co-immunoprecipitations were performed according to the
manufacturer's instructions (Roche, Basel, Switzerland). The lysates iso-
lated from P19CL6 cells were incubated with speciﬁc antibody or nor-
mal IgG for overnight at 4 °C with gentle rotation, and then with 50 μl
of protein G-Agarose (Roche) at 4 °C for 4 hwith gentle rotation. Immu-
noprecipitates were washed three times with wash buffer andFig. 1. Autophagy occurs in the early stage of cardiac differentiation of P19CL6 cells. (A) Autoph
Atg5, Atg7 and P62 at the indicated time-points was determined, and GAPDH was used as an i
induced P19CL6 cells under an electron microscope (bar = 1 μm). (C) The percentage of fra
with the control group at the indicated time-points. P19CL6 cells without DMSO induction we
at the same time-points.subjected to SDS-PAGE electrophoresis and were then detected with
speciﬁc antibodies.
2.8. Statistical analysis
The data are displayed asmean± standard deviation (SD). Compar-
isons were analyzed by Student's t-test or ANOVA. Signiﬁcance was an-
alyzed using the SPSS10.0 software and a P-value b0.05 was considered
to indicate statistical signiﬁcance.
3. Results
3.1. Autophagy occurs in the early stage of cardiac differentiation of P19CL6
cells
Todeterminewhether autophagy is involved in the process of P19CL6
differentiation, we ﬁrstly examined LC3 activation during the whole
stage of P19CL6 differentiation. The LC3 activation level was maintained
at the low level before day 3 of the induction, but it rapidly increasedagy was analyzed in DMSO-induced P19CL6 cells byWestern blot. The expression of LC3,
nternal control. (B) Autophagic vacuoles (arrowheads) were observed at day 3 in DMSO-
ctional area of autophagic vacuoles was calculated using Image-Pro Plus and compared
re used as the control. n = 10, each bar represents mean ± S.D. *P b 0.05 vs. the control
Fig. 2. Interfering Atg7 or Atg5 attenuates autophagy occurrence during the cardiac differentiation. P19CL6 cells were treated with siRNA against Atg7 (Atg7 RNAi), Atg5 (Atg5 RNAi),
or scramble RNA (Scramble) as the control, and then the following examinations were performed. (A) The activation of LC3 and expression of P62 were analyzed with Western blot at
the indicated time-points. GAPDHwas used as an internal control. (B) Electron microscopy was used to detect the autophagic vacuoles. The autophagic vacuoles are indicated by arrow-
heads (bar = 1 μm). (C) The percentage of fractional area of autophagic vacuoles was calculated using Image-Pro Plus. The Scramble group was used as the control. n = 10, each bar
represents mean ± S.D. *P b 0.05 compared with the Scramble group.
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two autophagy related genes, Atg5 and Atg7, also increased signiﬁcantly
from day 3, and on the contrary, P62 expression was reduced (Fig. 1A).
In order to observe the formation of autophagic vacuoles intuitively,
the electron microscopy was employed. Without DMSO induction,
the autophagic vacuoles in P19CL6 cells are hard to observe. On theFig. 3. Interfering autophagy blocks the cardiac differentiation. The expression of cardiac speciﬁ
stage markers (Gata4 and Isl1) or at day 12 for the later stage markers (α-Mhc, β-Mhc and tro
cardiac differentiation efﬁciency was calculated by counting the beating cells over the total c
with the Scramble group.contrary, the autophagic vacuoles were observed from day 3 in
P19CL6 cells treated with DMSO, and the fractional area of autophagic
vacuoles compared with the whole cell area was increased gradually
along with the days of differentiation (Fig. 1B, C). These data conﬁrm
that autophagy indeed occurs from the early stage of differentiation,
and maintained a high level at the late stage.c markers was analyzed by qRT-PCR (A, B) and Western blot (C, D) at day 4 for the early
ponin T) in P19CL6 cells treated with siRNA against Atg7, Atg5, or scramble RNA. (E) The
ell numbers at day 16 of induction. Each bar represents mean ± S.D. *P b 0.05 compared
Fig. 4. Autophagy inﬂuences Wnt and Notch signaling pathways. Luciferase reporter as-
says were performed by transfecting TOP/FOP Flash (A), Hes1 (B) or Hey1 (C) luciferase
reporter in the cells treatedwith or without rapamycin (Rapa, 200 nM, Sigma), an agonist
of autophagy, for 24 h. The cells treated with placebo were used as the control. Data are
shown as fold activation over that of the control with means + S.D. (n = 3). *P b 0.05
vs. the control.
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cardiac differentiation
To investigate whether the induction of autophagy has any effect on
P19CL6 differentiation, we established three cell lines: a cell line that
was stably knocked-down Atg7 (Atg7 RNAi), a cell line that was stably
knocked-down Atg5 (Atg5 RNAi), and a control cell line that was
transfected with scramble nucleotides (Scramble) (Fig. S2).
Western blot analysis indicated that when Atg7 or Atg5 was
knocked-down, LC3-II activation level was signiﬁcantly reduced during
the whole process of differentiation. Meanwhile, the expression of P62
was maintained in similar level as the Scramble group in Atg7 RNAi
group or sustained no change in Atg5 RNAi group (Fig. 2A). Electron
microscopy also showed that autophagy was signiﬁcantly inhibited
when Atg7 and Atg5 were knocked-down (Fig. 2B, C), suggesting that
Atg7 and Atg5, as in other physiological processes, play roles in the au-
tophagy occurrence during the cardiac differentiation.3.3. Interfering autophagy blocks the cardiac differentiation
Considering that Atg7 RNAi and Atg5 RNAi cell lines displayed lower
autophagy occurrence rate compared with the scramble cells, further
investigationwas carried out to explore whether the two genes are cor-
related with cardiac differentiation. Real-time RT-PCR analysis demon-
strated that compared to scramble cells, when we knocked-down Atg7
or Atg5 expression, the expression of some cardiac speciﬁc markers,including Gata4 and Isl1 (the early-stage markers, Fig. 3A) and Troponin
T, α-Mhc (αmyosin heavy chain) and β-Mhc (β myosin heavy chain)
(the late-stage markers, Fig. 3B), was notably decreased in the Atg7 or
Atg5 knocked-down cells. Western blot assay also indicated that
knocking-down of Atg7 or Atg5 inﬂuences the expression of GATA4
(Fig. 3C) and Troponin T (Fig. 3D).
As themost intuitive cell morphology, the P19CL6 beating efﬁciency
was calculated, and the results showed that when autophagy was
blocked by Atg7 or Atg5 RNAi, the counting of P19CL6 beating cells
was remarkably lower than those of the control cells (Fig. 3E). The re-
sults suggest that endogenous autophagy occurrence is correlated
with cardiac differentiation.
3.4. Autophagy inﬂuences Wnt and Notch signaling pathways during the
cardiac differentiation
Wehave demonstrated that autophagy is essential for cardiac differ-
entiation. Next, we investigated how autophagy affects the cardiac dif-
ferentiation. It has been reported that autophagy can interfere Wnt
and Notch signaling pathways in cancer development and Drosophila
oogenesis. Therefore, we examined whether Wnt and Notch signaling
pathways can be regulated by autophagy during the cardiac differentia-
tion of P19CL6 cells. TOP/FOP-Flash reporter assay demonstrated that
the application of rapamycin, an autophagy agonist, resulted in de-
creased TOP/FOP Flash luciferase activity of the reporter. When Atg7 or
Atg5 was knocked-down, the addition of rapamycin failed to affect
TOP/FOP Flash luciferase activity of the reporter in P19CL6 cells (Fig. 4A).
The inﬂuence of autophagy on Notch signaling pathway was consis-
tent with the data obtained on Wnt signaling pathway. The addition of
rapamycin resulted in decreased luciferase activity of the reporters that
harbor Hes1 promoter (Fig. 4B) or Hey1 promoter (Fig. 4C), the direct
downstream targets of Notch signaling pathway. Meanwhile, the
knock-down of Atg7 or Atg5 blocked the rapamycin effect (Fig. 4B, C).
These data demonstrate that the classical Wnt/β-catenin and Notch
pathways can be regulated by autophagy during the cardiac differentia-
tion, which led us to explore the detailed molecular mechanism.
3.5. Autophagy could promote the degradation of β-catenin and NICD
It has been reported that autophagy can negatively regulate Wnt
and Notch signaling pathways but the mechanism is not well under-
stood. During the cardiac differentiation process of P19CL6 cells, the ex-
pression of Wnt3a (Fig. S3A), Notch1 (Fig. S3B), β-catenin and NICD1
(Fig. S3C) exhibited a speciﬁc expression pattern, indicating that Wnt
and Notch signaling pathways were activated at the early stage of
cardiac differentiation. Immunoﬂuorescence staining demonstrated
that LC3 is located in β-catenin and NICD at day 4 of induction
(Fig. 5A), suggesting that LC3 might form a complex with β-catenin
and NICD. To verify this hypothesis, co-IP assay was employed at day
4 of differentiation, the results showed that LC3 formed a complex
with β-catenin (Fig. 5B) and NICD (Fig. 5C), respectively. Co-IP assay
demonstrated that P62 was also contained in the complex with β-
catenin (Fig. 5D) and NICD (Fig. 5E). As we know, P62 is an important
adaptor in selective autophagy [24]. It recognizes Ub substrates and
transports these ubiquitinated proteins into larger aggregates for
autophagic degradation. So we detected the status of ubiquitination by
Western blot assay. The results showed that ubiquitination mainly oc-
curred in small molecular weight proteins at day 0 and occurred in
large molecular weight proteins at day 4 or day 8 (Fig. S4A). Co-IP
assay results also demonstrated that ubiquitinated NICD or β-catenin
at day 4 was more than those at day 0 (Fig. S4B).
We also tested whether autophagy activation could increase the in-
teraction of LC3 with β-catenin or NICD. Immunoﬂuorescence assay
showed that when the autophagy was activated by rapamycin at day
0 of differentiation, the formation of complex which includes LC3 and
β-catenin (Fig. 5F) or NICD (Fig. 5G) was signiﬁcantly induced.
Fig. 5. Autophagy promotes the degradation of β-catenin and NICD. (A) Immunoﬂuorescence staining was performed in P19CL6 cells induced by DMSO for 4 days. Endogenous expres-
sion and distribution ofβ-catenin and LC3 orNICD and LC3were observed under the confocalmicroscope. The colocation of β-catenin and LC3 or NICD and LC3 is indicated by arrowheads
(bar=20 μm). (B) The cell lysates of P19CL6 cells induced to day 4were coprecipitatedwith anti-LC3 antibody or normal IgG as a control antibody, and then detected by anti-β-catenin or
anti-NICD antibody, 10% of total cell lysates were used as input. (C) The cell lysates of P19CL6 cells induced to day 4 were coprecipitated with anti-β-catenin and anti-NICD antibody, or
normal IgG as a control antibody, and then detected by anti-LC3 antibody, 10% of total cell lysates were used as input. (D) The cell lysates of P19CL6 cells induced to day 4 were
coprecipitated with anti-P62 antibody or IgG as a control antibody, and then detected by anti-β-catenin or anti-NICD antibody, 10% of total cell lysates were used as input. (E) The cell
lysates of P19CL6 cells induced to day 4 were coprecipitated with anti-β-catenin and anti-NICD antibody, or normal IgG as a control antibody, and then detected by anti-P62 antibody,
10% of total cell lysateswere used as input. (F, G) Immunoﬂuorescence stainingwas performed in P19CL6 cells treatedwith orwithout rapamycin (Rapa, 200 nM). Endogenous expression
and distribution of β-catenin and LC3 or NICD and LC3were observed (bar= 20 μm). (H) P19CL6 cells were induced by DMSO to day 4, and then treatedwith rapamycin (Rapa, 200 nM),
3-methyladenine (3-MA, 10 mM, Sigma) or MG-132 (10 μM, Sigma), respectively. Total protein was isolated forWestern blot analysis to detect the endogenous expression of β-catenin,
NICD, LC3 or P62. GAPDH was used as an internal control.
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the redundant cellular proteins. Wnt and Notch signaling pathways
must be turned down at a certain stage of cardiac differentiation. It is in-
teresting to know whether autophagy mediates the degradation of
some component molecules in these two signaling pathways. Western
blot results demonstrated that the level of β-catenin and NICD was
signiﬁcantly decreased in the cells treated with rapamycin [25], an au-
tophagy agonists, along with enhanced LC3 activation and decreased
P62 expression.While whenwe treated the cells with 3-MA [26], an au-
tophagy inhibitor, the autophagy occurrence was blocked and the ex-
pression of β-catenin and NICD was increased (Fig. 5H). In order to
exclude the effect of proteasome pathway, the cells were treated with
proteasome inhibitor MG-132 [27]. There was almost no change on
the expression of β-catenin and NICD, as well as LC3 and P62, compared
with the control cells treated with placebo. This indicates that autopha-
gy could inﬂuence theWnt and Notch signaling pathways via accelerat-
ing the degradation of β-catenin and NICD.4. Discussion
Themain aimof our studywas to determine the association between
autophagy and differentiation related signaling pathways and its role
during the process of cardiomyocyte differentiation.It was well known that autophagy takes part in adipogenesis and
neuron development. However, how autophagy contributes to develop-
ment is not well understood, although it has been proposed that au-
tophagy may inﬂuence cell differentiation either by impairing new
protein synthesis or new organelle formation or by accelerating turn-
over of redundant proteins or organelles. Atg7 plays an important role
in normal adipogenesis by inferring autophagy and the disruption of
Atg7 gene has a unique anti-obesity and insulin sensitization effect
[28]. Ambra1 is a positive regulator of the Beclin1-dependent program
of autophagy and its functional deﬁciency in mouse embryos leads to
severe neural tube defects associated with autophagy impairment, ac-
cumulation of ubiquitinated proteins, unbalanced cell proliferation
and excessive apoptotic cell death [29].
As we know that autophagy plays important roles in development
[30], there are few reports in the ﬁeld of myocardial differentiation.
Inhibiting FRS2-αmediated signals increases autophagy and promotes
myocardial differentiation [31].
In the heart, FIP200 (focal adhesion kinase (FAK) family kinase-
interacting protein of 200 kDa, also known as RB1CC1) is a ULK1 (an
Atg1 homologue)-interacting protein and has a molecular function
similar to that of yeast Atg17, although it shows no sequence homology
with any yeast Atg proteins [32]. FIP200−/− mice are also embry-
onically lethal between E13.5 and E16.5 as a result of defective heart
and liver development [33].
2305Z. Jia et al. / Cellular Signalling 26 (2014) 2299–2305All these literatures have demonstrated that autophagy plays impor-
tant roles in differentiation or development. As autophagy usually af-
fects its functions by eliminating protein which should be degraded,
how autophagy inﬂuences differentiation is to be considered. Wnt,
activin/Nodal, BMP, FGF andNotch signaling pathways have been inves-
tigated extensively for their roles during cardiogenesis. We previously
documented a speciﬁc reciprocal interaction between Wnt and Notch1
signaling pathways during the early stage of cardiac differentiation of
P19CL6 cells [3].
Wnt/β-catenin signaling pathway is centered on β-catenin. In the
absence of canonical Wnt signaling, β-catenin complex with APC
and AXIN is phosphorylated by glycogen synthase kinase 3β (GSK3β)
in a degradation box,which is polyubiquitinated for proteasomal degra-
dation [34]. In the presence of Wnt ligands, binding to its receptor
complex, GSK3β is inhibited, leading to the stabilization of cytoplasmic
β-catenin. Accumulated cytoplasmic β-catenin subsequently translo-
cates to the nucleus and initiates its target genes' transcription through
T-cell factor (TCF)–lymphoid enhancer factor (LEF) transcription factors
[35,36].
Notch signaling plays important roles in determining cell fate during
development and is activated upon cell-to-cell contact as a result of
interactions between Notch receptors and their ligands (Delta or
Jagged). Ligand binding results in proteolytic cleavage of Notch recep-
tors by γ-secretases, leading to the release of a 80-kDa intracellular do-
main of Notch (NICD), which then translocates to the nucleus and
complexes with the transcription factor recombination signal sequence
binding protein-Jkappa (RBP-Jk) to activate the transcription of its
downstream target genes [37].
Through our study, we found that Wnt and Notch signaling
pathways were both activated at the early stage of differentiation, sug-
gesting that the two signaling pathways could promote cardiac differen-
tiation, but at the late stage, both signaling pathways were closed,
in which many mechanisms might be involved. As one of the protein
elimination pathway, whether autophagy played important roles in
degrading the long-lived proteins, such as β-catenin and NICD, is still
unknown. Our results indicate that autophagy could inﬂuence the
Wnt and Notch signaling pathways via accelerating the degradation of
β-catenin and NICD.
5. Conclusion
Our results provide evidence for the function of autophagy in cardiac
differentiation.When autophagy is inhibited, the cardiac differentiation
is reduced. The main effectors of Wnt and Notch signaling pathways, β-
catenin and NICD, could form a complex with LC3 and P62 and could
then be degraded by autophagy. As both Notch and Wnt pathways
play inhibitory roles in the late stage of cardiac differentiation, autoph-
agy could facilitate P19CL6 cells to complete the cardiac differentiation
process through inhibiting Wnt and Notch signaling pathways.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.cellsig.2014.07.028.
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